The specialist integrated CDMO

Browser not supported

Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:

Knowledge Center

Webinar

Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO

Jan 26, 2023 Webinar

Patent

Process to reduce ivermectin particle size

Dec 08, 2022 WO 2022254199

Patent

Method for synthesizing 9-aminomethyl tetracycline compounds

Dec 01, 2022 WO 2022248865

Webinar

Webinar - Dispersome® – Understanding formulation principles and manufacturing behind this new Bioavailability Enhancing Technology

Sep 08, 2022 Webinar

Patent

Inhaled ivermectin

Aug 04, 2022 US 20220241307

Patent

Drying of pharmaceutical powders

Jul 28, 2022 WO 2022157135

Article

Multivalent NHS-activated acrylates for orthogonal site-selective functionalisation of peptides at cysteine residues

Jun 20, 2022 Chemical Communications (Cambridge, United Kingdom), june 20, 2022

Article

Semi-continuous and continuous processes for enantiomeric separation

May 20, 2022 Green Chemistry, May 20, 2022

Poster

Use of PAT tools in the development, monitor and control of continuous manufacturing processes

May 03, 2022 3rd APV Continuous Manufacturing Conference 2022

Poster

Enhancing the “right first time” concept in Continuous Manufacturing – Development strategy

May 03, 2022 3rd APV Continuous Manufacturing Conference 2022

Patent

Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders

Apr 28, 2022 US 20220125829

Webinar

Webinar - Leveraging Particle Engineering towards delivery of Biopharmaceuticals

Mar 24, 2022 Webinar

Browser not supported

Knowledge Center

Scientific Article Type

Authors

Publish Date

Webinar - Accelerating the Adoption of Continuous Tableting: The Responsibility of a CDMO

Process to reduce ivermectin particle size

Method for synthesizing 9-aminomethyl tetracycline compounds

Webinar - Dispersome® – Understanding formulation principles and manufacturing behind this new Bioavailability Enhancing Technology

Inhaled ivermectin

Drying of pharmaceutical powders

Multivalent NHS-activated acrylates for orthogonal site-selective functionalisation of peptides at cysteine residues

Semi-continuous and continuous processes for enantiomeric separation

Use of PAT tools in the development, monitor and control of continuous manufacturing processes

Enhancing the “right first time” concept in Continuous Manufacturing – Development strategy

Methods and compositions for treating meibomian gland dysfunction, dry eye disease, and related disorders

Webinar - Leveraging Particle Engineering towards delivery of Biopharmaceuticals